Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUCLID PAD ticagrelor versus clopidogrel trial
NL-OMON41255Phase 3Active, not recruiting
- Sponsor
- AstraZeneca
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ticagrelor and clopidogrel, sponsored by AstraZeneca. Started Jan 2013; status: active, not recruiting.
02
Drugs
ticagrelorclopidogrel
Beyond the preview
Go deeper on NL-OMON41255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41255.